Raia Drogasil S.A. (BVMF:RADL3)

Market Cap	41.20B +27.1%
Revenue (ttm)	44.25B +13.8%
Net Income	1.30B +8.1%
EPS	0.78 +10.0%
Shares Out	1.75B
PE Ratio	30.16
Forward PE	23.06
Dividend	0.30 (1.26%)
Ex-Dividend Date	Dec 8, 2025

Volume	16,113,300
Average Volume	10,196,760
Open	23.88
Previous Close	23.65
Day's Range	23.40 - 24.17
52-Week Range	12.81 - 27.42
Beta	0.16
RSI	37.54
Earnings Date	Mar 3, 2026

About Raia Drogasil

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics and specialty medicines in Brazil. The company sells its products through stores, telesales, and call centers. Raia Drogasil S.A. was founded in 1905 and is headquartered in São Paulo, Brazil.

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1905
• Employees: 73,895
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: RADL3

Financial Performance

In 2025, Raia Drogasil's revenue was 44.25 billion, an increase of 13.84% compared to the previous year's 38.87 billion. Earnings were 1.30 billion, an increase of 8.08%.